- Report
- October 2025
- 474 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 178 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 180 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 196 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- October 2025
- 413 Pages
Global
From €5171EUR$5,850USD£4,502GBP
- Report
- September 2025
- 250 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- September 2025
- 250 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- September 2025
- 250 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- July 2025
- 175 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- April 2025
- 175 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- April 2025
- 175 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- April 2025
- 175 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- April 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- April 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- February 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- February 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- February 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- February 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- February 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP
- Report
- February 2025
- 200 Pages
Global
From €3969EUR$4,490USD£3,456GBP

Biomarker Discovery is a field of research that focuses on the identification and characterization of biomarkers, which are biological molecules that can be used to measure and monitor the progression of a disease or condition. Biomarkers can be used to diagnose, predict, and monitor the effectiveness of treatments. They can also be used to identify individuals at risk of developing a disease or condition.
Biomarker Discovery is a rapidly growing field, with many companies investing in research and development. Companies such as Illumina, Qiagen, and Thermo Fisher Scientific are leading the way in developing new technologies and products for biomarker discovery. Other companies such as Roche, Abbott, and Agilent Technologies are also investing in biomarker discovery, offering a range of products and services. Show Less Read more